MC is known to be associated with MSI-H, and some studies examining the immunohistochemical characteristics of this tumor have shown that it can be differentiated from poorly differentiated colorectal adenocarcinoma by a loss of MLH-1 staining and the intestinal transcription factor CDX2. The gene discussed is CDX2; the disease is colorectal adenocarcinoma.